Wyszukiwarka
Filtry
wszystkich: 7
Wyniki wyszukiwania dla: efekt ggke (glutathione-gated potassium efflux)
-
Preliminary Investigation on Rapid Potassium Efflux from Activated Sludge in Response to Use of Peroxyacetic Acid
PublikacjaPreliminary research on activated sludge potassium efflux (GGKE - glutathione-gated potassium efflux) as a result of peroxyacetic acid (PAA) dosing were performed. Similarily as in case of chlorine dosing the PAA dosing causes initiation of bacteria defense mechanisms, related to the transformations of glutathione tripeptide, resulting in the increase of potassium ions concentration in the activated sludge environment. In the range...
-
Release of potassium from actvated sludge as a resultof use peroxyacetic acid = Uwalnianie potasu z osadu czynnego pod wpływem kwasu nadoctowego
PublikacjaThe phenomenon of potassium efflux (GGKE - glutathione-gated potassium efflux) from the calls of activated sludge bacteria in the result of peroxyacetic acid (CH3CO3H) dosing was investigated. Addition of the strong oxidant to the activated sludge environment caused activation of the defense mechanisms of bacterial cells, related to glutathione transformations, which resulted in the significant increase of potassium ions concentration....
-
Uwalnianie potasu przez bakterie osadu czynnego jako reakcja na stosowanie kwasu nadoctowego
PublikacjaBadanie efektu wypływu potasu (GGKE - glutathione-gated potassium efflux) z komórek bakterii osadu czynnego pod wpływem dawkowania kwasu nadoctowego (CH3CO3H). Wzrost stężenia jonów potasu w środowisku osadu czynnego był uzależniony od wielkości dawek kwasu nadoctowego. Maksymalne przyrosty stężeń K+ dla wszystkich zastosowanych dawek kwasu nadoctowego obserwowano po 15-20 minutach reakcji.
-
The Substantial Improvement of Amphotericin B Selective Toxicity Upon Modification of Mycosamine with Bulky Substituents
PublikacjaAbstract: Background: It is assumed that the unfavorable selective toxicity of an antifungal drug Amphotericin B (AmB) can be improved upon chemical modification of the antibiotic molecule. Objective: The aim of this study was verification of the hypothesis that introduction of bulky substituents at the amino sugar moiety of the antibiotic may result in diminishment of mammalian vitro toxicity of thus prepared AmB derivatives. Methods:...
-
Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils
PublikacjaThe antimicrobial activity of plant oils and extracts has been recognized for many years. In this study the activity of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimumbasilicum, and Eugenia caryophyllus essential oils (EOs) distributed by Pollena Aroma (Nowy Dwór Mazowiecki, Poland) was investigated against a group of 183 clinical isolates of C. albicans and 76 isolates of C. glabrata. All of...
-
Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by antitumor triazoloacridinone C-1305.
Publikacja5-Dimethylaminopropylamino-8-hydroxytriazoloacridinone, C-1305, is a promising antitumor therapeutic agent with high activity against several experimental tumors. It was determined to be a potent and selective inhibitor of liver microsomal and human recombinant cytochrome P450 (CYP) 1A2 and 3A4 isoenzymes. Therefore, C-1305 might modulate the effectiveness of other drugs used in multidrug therapy. The objective of this study was...
-
Imidazoacridinone antitumor agent C-1311 as a selective mechanism- based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes.
Publikacja5-Diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311), a promising antitumor agent that is also active against autoimmune diseases, was determined to be a selective inhibitor of the cytochrome P450 (CYP) 1A2 and 3A4 isoenzymes. Therefore, C-1311 might modulate the effectiveness of other drugs used in multidrug therapy. The present work aimed to identify the mechanism of the observed C-1311-mediated inactivation of CYP1A2...